Semih Başçı

551 total citations
53 papers, 272 citations indexed

About

Semih Başçı is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Semih Başçı has authored 53 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 21 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Semih Başçı's work include Lymphoma Diagnosis and Treatment (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). Semih Başçı is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). Semih Başçı collaborates with scholars based in Türkiye, Cambodia and Somalia. Semih Başçı's co-authors include Fevzi Altuntaş, Tuğçe Nur Yiğenoğlu, Mehmet Sinan Dal, Tuba Hacıbekiroğlu, Mustafa Mahir Ülgü, Mehmet Ali Erkurt, Kürşat Dal, Sinem Namdaroğlu, Osman Çelik and Abdulkadir Baştürk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Journal of Medical Virology.

In The Last Decade

Semih Başçı

43 papers receiving 267 citations

Peers

Semih Başçı

ONCOL

HEMAT

PFM

GENET

Dominic Kaddu‐Mulindwa Germany

David Bosler United States

Mehmet Hilmi Doğu Türkiye

Fehmi Hindilerden Türkiye

Tuğçe Nur Yiğenoğlu Türkiye

Joseph Lubega United States

Selena Longhi Italy

Lisa Y. Law United States

Clare Nasmyth‐Miller United Kingdom

Young Bae Choi South Korea

Dominic Kaddu‐Mulindwa Germany

Semih Başçı

100 ×0.8

ONCOL

71 ×0.7

44 ×0.8

HEMAT

76 ×1.5

PFM

58 ×1.6

GENET

Citations per year, relative to Semih Başçı Semih Başçı (= 1×) peers Dominic Kaddu‐Mulindwa

Countries citing papers authored by Semih Başçı

Since Specialization

Citations

This map shows the geographic impact of Semih Başçı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semih Başçı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semih Başçı more than expected).

Fields of papers citing papers by Semih Başçı

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Semih Başçı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semih Başçı. The network helps show where Semih Başçı may publish in the future.

Co-authorship network of co-authors of Semih Başçı

This figure shows the co-authorship network connecting the top 25 collaborators of Semih Başçı. A scholar is included among the top collaborators of Semih Başçı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Semih Başçı. Semih Başçı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Namdaroğlu, Sinem, et al.. (2024). Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting. Journal of Clinical Medicine. 13(17). 5145–5145. 1 indexed citations

Dal, Mehmet Sinan, Tuğçe Nur Yiğenoğlu, Semih Başçı, et al.. (2023). Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey. Journal of Chemotherapy. 35(6). 563–569. 2 indexed citations

Başçı, Semih, et al.. (2023). Characteristics and Outcome of Patients with Chronic Myelomonocytic Leukemia: Experience of a Single Center. Acta Oncologica Turcica. 56(1). 27–32. 1 indexed citations

Kaçmaz, Murat, Semih Başçı, Tuğçe Nur Yiğenoğlu, et al.. (2023). Uric Acid and Multiple Myeloma, Unexplored Association. Acta Oncologica Turcica. 56(1). 46–52. 1 indexed citations

Başçı, Semih, et al.. (2022). Prognostic value of neutrophil/lymphocyte ratio, lymphocyte/monocyte ratio, lactate dehydrogenase, and mean platelet volume in the diagnosis of patients with diffuse large B-cell lymphoma. The Egyptian Journal of Haematology. 47(4). 233–238. 2 indexed citations

Dal, Mehmet Sinan, Olga Meltem Akay, Özgür Mehtap, et al.. (2021). Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. Journal of Chemotherapy. 34(3). 190–198. 8 indexed citations

Dal, Mehmet Sinan, et al.. (2021). Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey. Medicine. 100(41). e27458–e27458.

Yiğenoğlu, Tuğçe Nur, et al.. (2021). Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma. Leukemia Research. 110. 106700–106700. 6 indexed citations

Başçı, Semih, et al.. (2021). Does myeloma genetic have an effect on stem cell mobilization?. Transfusion and Apheresis Science. 60(6). 103249–103249. 1 indexed citations

10.

Yiğenoğlu, Tuğçe Nur, Semih Başçı, Tuba Hacıbekiroğlu, et al.. (2021). Does Total Body Irradiation Have a Favorable Impact on Thrombocyte Engraftment as per Neutrophil Engraftment in Allogeneic Stem Cell Transplantation?. Cureus. 13(11). e19462–e19462. 1 indexed citations

11.

Başçı, Semih, et al.. (2021). Single-Dose Rasburicase Might Be Adequate To Overcome Tumor Lysis Syndrome In Hematological Malignancies. Clinical Lymphoma Myeloma & Leukemia. 22(2). e71–e76. 5 indexed citations

12.

Başçı, Semih, et al.. (2021). A Case of Hypopharyngeal Cancer Associated With Fanconi Anemia: A Helical Tomotherapy Experience. Cureus. 13(11). e19386–e19386.

13.

Yiğenoğlu, Tuğçe Nur, et al.. (2020). Second allogeneic stem cell transplantation in acute leukemia patients: single-centre experience. SHILAP Revista de lepidopterología. 9(1). 87–96.

14.

Başçı, Semih, Mehmet Sinan Dal, Merih Kızıl Çakar, et al.. (2020). Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(2). 685–692. 4 indexed citations

15.

Yiğenoğlu, Tuğçe Nur, Semih Başçı, Tahir Darçın, et al.. (2020). The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors. Transfusion and Apheresis Science. 59(3). 102726–102726. 1 indexed citations

16.

Yiğenoğlu, Tuğçe Nur, Semih Başçı, Tahir Darçın, et al.. (2020). Inferior prognosis in poor mobilizing myeloma patients. Transfusion and Apheresis Science. 59(3). 102722–102722. 5 indexed citations

17.

Başçı, Semih, et al.. (2020). The Outcome of Diffuse Large B Cell Lymphoma Patients in Adolescent and Young Adult Age Group. Journal of Adolescent and Young Adult Oncology. 10(4). 483–487. 2 indexed citations

18.

Yiğenoğlu, Tuğçe Nur, et al.. (2020). Blood group A is a negative risk factor for peripheric blood stem cell mobilization in allogeneic donors. Medical Science and Discovery. 7(6). 505–508. 1 indexed citations

19.

Başçı, Semih, Tuğçe Nur Yiğenoğlu, Tahir Darçın, et al.. (2020). Old is bad? The effect of age on peripheral stem cell mobilization and transplantation outcomes. Transfusion and Apheresis Science. 60(1). 103007–103007. 3 indexed citations

20.

Başçı, Semih, et al.. (2017). The relationship between vitamin D deficiency and increased mean platelet volume in renal transplant recipients. Medeniyet Medical Journal. 32(2). 106–110.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact